🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Madan Katragadda

Io Therapeutics (United States)

ORCID: 0009-0004-2394-6816
MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models”.

Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013158
N/A
0.165DataRank · unranked
2 citations

Ginette S. Santiago-Sánchez, Kellsye P. Fabian, Michelle R. Padget, J Lee, Clint Allen +7 more

A T cell receptor β chain–directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity

Science Translational Medicine(2023)10.1126/scitranslmed.adi0258
N/A
0DataRank · unranked
23 citations

Renee N. Donahue, Madan Katragadda, Jessica Lowry, Wei Huang, Karunya Srinivasan +15 more